DOI QR코드

DOI QR Code

A Case of P-ANCA-Positive Anti-Glomerular Basement Membrane Antibody Disease

P-ANCA 양성 항사구체기저막 항체 질환 1예

  • Chung, Hyun Ah (Department of Internal Medicine, Konkuk University School of Medicine) ;
  • Son, In Sung (Department of Internal Medicine, Konkuk University School of Medicine) ;
  • Hwang, Yong (Department of Internal Medicine, Konkuk University School of Medicine) ;
  • Choi, Hong Seok (Department of Internal Medicine, Konkuk University School of Medicine) ;
  • Kim, Do Young (Department of Internal Medicine, Konkuk University School of Medicine) ;
  • Lim, So Duk (Department of Pathology, Konkuk University School of Medicine) ;
  • Jo, Young Il (Department of Internal Medicine, Konkuk University School of Medicine)
  • 정현아 (건국대학교 의과대학 내과학교실) ;
  • 손인성 (건국대학교 의과대학 내과학교실) ;
  • 황용 (건국대학교 의과대학 내과학교실) ;
  • 최홍석 (건국대학교 의과대학 내과학교실) ;
  • 김도영 (건국대학교 의과대학 내과학교실) ;
  • 임소덕 (건국대학교 의과대학 병리과학교실) ;
  • 조영일 (건국대학교 의과대학 내과학교실)
  • Published : 2012.12.01

Abstract

Up to 40% of patients with anti-glomerular basement membrane (GBM) disease, which is a rare autoimmune disorder usually manifesting as rapidly progressive glomerulonephritis (RPGN), are positive for circulating anti-neutrophil cytoplasmic antibody (ANCA). Many previous reports showed poor outcomes in these "double-positive" patients. We report a patient with perinuclear (p)-ANCA positive anti-GBM disease who presented with RPGN and required hemodialysis. Plasmapheresis and steroid and cyclophosphamide therapy were initiated following renal biopsy and resulted in normalization of anti-GBM antibody and p-ANCA titers, recovery of renal function, and discontinuation of hemodialysis. This case suggests that aggressive immunosuppression with plasmapheresis in patients who are p-ANCA positive with anti-GBM disease should be considered, even in those with severe renal dysfunction.

항사구체기저막 항체 질환은 드문 자가면역성 질환으로 급속 진행성 사구체신염으로 흔히 발현된다. 많게는 40%의 환자에서 ANCA가 양성인데, 이렇게 항사구체기저막 항체와 ANCA가 모두 양성인 경우에는 대체로 예후가 좋지 않다. 저자들은 p-ANCA가 양성인 항사구체기저막 항체 질환으로 투석이 필요했던 59세 여자 환자에서 혈장분리교환술과 적극적인 면역억제 치료로 신기능의 회복을 보여 투석치료를 중지한 급속 진행성 사구체신염 1예를 경험하였기에 문헌고찰과 함께 보고한다.

Keywords

References

  1. Bolton WK. Goodpasture's syndrome. Kidney Int 1996;50:1753-1766. https://doi.org/10.1038/ki.1996.495
  2. Levy JB, Hammad T, Coulthart A, Dougan T, Pusey CD. Clinical features and outcome of patients with both ANCA and anti-GBM antibodies. Kidney Int 2004;66:1535-1540. https://doi.org/10.1111/j.1523-1755.2004.00917.x
  3. Lee KH, Lee DR, Kim KH, et al. A case of anti-glomerular basement membrane antibody associated crescentic glomerulonephritis with positive antineutrophilic cytoplasmic antibody. Korean J Nephrol 1999;18:656-660.
  4. Ryu JI, Cho KH, Heo SW, et al. A case of rapidly progressive glomerulonephitis associated with anti-glomerular basement membrane antibody and p-antineutrophilic cytoplasmic antibody. Korean J Nephrol 2002;21:691-696.
  5. Bosch X, Mirapeix E, Font J, et al. Prognostic implication of anti-neutrophil cytoplasmic autoantibodies with myeloperoxidase specificity in anti-glomerular basement membrane disease. Clin Nephrol 1991;36:107-113.
  6. Segelmark M, Hellmark T, Wieslander J. The prognostic significance in Goodpasture's disease of specificity, titre and affinity of anti-glomerular-basement-membrane antibodies. Nephron Clin Pract 2003;94:c59-c68. https://doi.org/10.1159/000072022
  7. Lindic J, Vizjak A, Ferluga D, et al. Clinical outcome of patients with coexistent antineutrophil cytoplasmic antibodies and antibodies against glomerular basement membrane. Ther Apher Dial 2009;13:278-281. https://doi.org/10.1111/j.1744-9987.2009.00724.x
  8. Hellmark T, Segelmark M, Unger C, Burkhardt H, Saus J, Wieslander J. Identification of a clinically relevant immunodominant region of collagen IV in Goodpasture disease. Kidney Int 1999;55:936-944. https://doi.org/10.1046/j.1523-1755.1999.055003936.x
  9. Yang R, Hellmark T, Zhao J, et al. Levels of epitope-specific autoantibodies correlate with renal damage in anti-GBM disease. Nephrol Dial Transplant 2009;24:1838-1844. https://doi.org/10.1093/ndt/gfn761
  10. Yang R, Hellmark T, Zhao J, et al. Antigen and epitope specificity of anti-glomerular basement membrane antibodies in patients with goodpasture disease with or without anti-neutrophil cytoplasmic antibodies. J Am Soc Nephrol 2007;18:1338-1343. https://doi.org/10.1681/ASN.2006111210
  11. Glassock RJ. Intensive plasma exchange in crescentic glomerulonephritis: help or no help? Am J Kidney Dis 1992;20:270-275. https://doi.org/10.1016/S0272-6386(12)80700-1
  12. Japanese Society of Nephrology. Guidelines for the treatment of rapidly progressive glomerulonephritis, second version. Nihon Jinzo Gakkai Shi 2011;53:509-505.